Stathopoulos P, et al. The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders. Expert Rev Clin Immunol.2022 Jul 29;1-13.
 Chamberlain JL, et al. Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.J Neurol. 2021 May;268(5):1643-1664.